Debra Vanderhoff is the Founder and Chief Operating Officer of MicroLumix Bioscience Technologies. As a founding leader, she has shaped the company’s operational foundation and guided its transformation from an early-stage innovation concept into a rapidly expanding health technology enterprise focused on infrastructure-integrated protection systems.

Beyond her executive responsibilities, Debra is an inventor of multiple domestic and international patents involving automated disinfection technologies and contamination-control systems. Her work directly advances the company’s mission to embed environmental protection into critical public and healthcare infrastructure.

Recognized as a subject matter expert in High-Volume Touchpoint (HVT) infection control, Debra frequently contributes to industry discussions surrounding contamination mitigation and infrastructure-based protection strategies. She has served as a keynote speaker at the annual Sepsis World Congress, presenting on environmental transmission pathways and the role of automated disinfection technologies within healthcare environments.

At MicroLumix, Debra bridges strategy and execution across multiple divisions. She leads operational coordination for key initiatives, including the Center for Healthcare Threat Intelligence (CHTI) and the Pathogen Control Alliance (PCA). Working alongside engineering, regulatory, and clinical teams, she helps drive the deployment of MicroLumix’s Managed Contamination Infrastructure (MCI) platform across the healthcare, transportation, and public infrastructure sectors. Known for her hands-on leadership style and operational intensity, Debra specializes in transforming complex engineering and clinical challenges into scalable execution frameworks that support long-term growth and operational resilience.

“Building safer environments requires more than innovation alone. It takes disciplined execution, operational resilience, and a commitment to creating systems capable of protecting people at scale.” – Debra Vanderhoff